[go: up one dir, main page]

NO20052348D0 - Behandling av hemoragisk sjokk - Google Patents

Behandling av hemoragisk sjokk

Info

Publication number
NO20052348D0
NO20052348D0 NO20052348A NO20052348A NO20052348D0 NO 20052348 D0 NO20052348 D0 NO 20052348D0 NO 20052348 A NO20052348 A NO 20052348A NO 20052348 A NO20052348 A NO 20052348A NO 20052348 D0 NO20052348 D0 NO 20052348D0
Authority
NO
Norway
Prior art keywords
treatment
hemorrhagic shock
hemorrhagic
shock
Prior art date
Application number
NO20052348A
Other languages
English (en)
Other versions
NO20052348L (no
Inventor
Leo E Otterbein
Augustine M K Choi
Brian Zuckerbraun
Timothy R Billiar
Carol A Mccloskey
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Publication of NO20052348D0 publication Critical patent/NO20052348D0/no
Publication of NO20052348L publication Critical patent/NO20052348L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20052348A 2002-11-07 2005-05-12 Behandling av hemoragisk sjokk NO20052348L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42480402P 2002-11-07 2002-11-07
PCT/US2003/030956 WO2004043341A2 (en) 2002-11-07 2003-09-30 Treatment for hemorrhagic shock

Publications (2)

Publication Number Publication Date
NO20052348D0 true NO20052348D0 (no) 2005-05-12
NO20052348L NO20052348L (no) 2005-08-02

Family

ID=32312877

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052348A NO20052348L (no) 2002-11-07 2005-05-12 Behandling av hemoragisk sjokk

Country Status (13)

Country Link
US (1) US20040228930A1 (no)
EP (1) EP1558084A4 (no)
JP (1) JP2006514621A (no)
CN (1) CN1719975A (no)
AU (1) AU2003283982A1 (no)
CA (1) CA2504604A1 (no)
EA (1) EA200500782A1 (no)
HR (1) HRP20050389A2 (no)
MX (1) MXPA05004924A (no)
NO (1) NO20052348L (no)
PL (1) PL377733A1 (no)
RS (1) RS20050344A (no)
WO (1) WO2004043341A2 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7678390B2 (en) 1999-04-01 2010-03-16 Yale University Carbon monoxide as a biomarker and therapeutic agent
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
NZ562962A (en) * 2001-06-21 2009-08-28 Fritz H Bach Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
EP1476168A2 (en) 2002-02-04 2004-11-17 ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
HRP20040972A2 (en) 2002-04-15 2005-06-30 University Of Pittsburgh Of The Commonwealth Systeyale University Methods of treating ileus
RS91104A (sr) * 2002-04-15 2007-02-05 University Of Pittsburgh Of The Commonwealth System Of Higher Education, Postupci za lečenje nekrotizujućeg enterokolitisa
AU2003226366A1 (en) 2002-04-15 2003-11-03 Beth Israel Deaconess Medical Center Use of heme oxygenase-1 and products of heme degradation
PL205066B1 (pl) 2002-05-17 2010-03-31 Univ Pittsburgh Zastosowanie tlenku węgla do wytwarzania kompozycji farmaceutycznej
PL374375A1 (en) * 2002-06-05 2005-10-17 Yale University Methods of treating angiogenesis, tumor growth, and metastasis
EA200500062A1 (ru) * 2002-06-21 2005-06-30 Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн Фармацевтическое применение оксида азота, гемоксигеназы-1 и продуктов деградации гема
GB2395432B (en) 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
JP2007509163A (ja) 2003-10-22 2007-04-12 フレッド ハッチンソン キャンサー リサーチ センター 組織および臓器においてスタシスを誘導する方法、組成物、および装置
US8893717B2 (en) 2005-09-21 2014-11-25 Ino Therapeutics Llc Systems and methods of administering a pharmaceutical gas to a patient
US7523752B2 (en) 2005-09-21 2009-04-28 Ino Therapeutics, Llc System and method of administering a pharmaceutical gas to a patient
US7745402B2 (en) * 2005-09-30 2010-06-29 Lundbeck Inc. Method of treating pancreatitis
WO2007073005A1 (ja) * 2005-12-22 2007-06-28 Keio University メチル基転移反応調節物質
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
JP5020525B2 (ja) * 2006-03-30 2012-09-05 財団法人生産開発科学研究所 配位子置換型輸液製剤
US7766857B2 (en) * 2006-08-21 2010-08-03 General Electric Company Non-invasive determination of cardiac output, gas exchange and arterial blood gas concentration
TWI474824B (zh) * 2006-11-07 2015-03-01 Gen Hospital Corp 血管活性氧載劑所引發之血管收縮之減輕
AU2007328549A1 (en) * 2006-12-06 2008-06-12 Alfama - Investigacao E Desenvolvimento De Produtos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
ES2512066T3 (es) 2009-03-05 2014-10-23 The Uab Research Foundation Potenciación de la coagulación o reducción de la fibrinólisis
CN103491783A (zh) 2011-01-14 2014-01-01 洛杉矶儿童医院 用于治疗包括镰状细胞疾病的疾病的一氧化碳溶液
WO2012145520A2 (en) 2011-04-19 2012-10-26 Alfama, Inc. Carbon monoxide releasing molecules and uses thereof
ES2628634T3 (es) 2011-07-21 2017-08-03 Alfama, Inc. Moléculas liberadoras de monóxido de carbono-rutenio y usos de las mismas
CA2844660A1 (en) 2011-08-09 2013-02-14 Leo E. Otterbein Methods of treating dna damage
US20220257722A1 (en) * 2019-03-28 2022-08-18 United States Government As Represented By The Department Of Veterans Affairs Compositions and methods of treating and preventing systemic complications of acute illness

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053590A (en) * 1975-02-27 1977-10-11 Alza Corporation Compositions of matter comprising macromolecular hemoglobin
US4264739A (en) * 1979-01-05 1981-04-28 Merck & Co., Inc. Sparger for cell culture system
US5240912A (en) * 1983-05-09 1993-08-31 Todaro George J Transforming growth factor (TGF) peptides
US5084380A (en) * 1985-01-29 1992-01-28 Applied Biotechnology Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
US5449665A (en) * 1985-09-24 1995-09-12 Item Development Aktiebolag Continuous intravenous infusion of adenosine to human patients undergoing percutaneous transluminal angioplasty
DE3739650C1 (de) * 1987-11-23 1989-05-24 Immuno Ag Fermenter zum Zuechten von Zellkulturen
US5180366A (en) * 1990-10-10 1993-01-19 Woods W T Apparatus and method for angioplasty and for preventing re-stenosis
US5792325A (en) * 1990-11-15 1998-08-11 Richardson, Jr.; William H. Electric arc material processing system
US5293875A (en) * 1992-06-16 1994-03-15 Natus Medical Incorporated In-vivo measurement of end-tidal carbon monoxide concentration apparatus and methods
ES2219646T5 (es) * 1993-02-22 2008-11-01 Abraxis Bioscience, Inc. Metodos para la administracion in vivo de compuestos biologicos y composiciones utiles para los mismos.
ES2062943B1 (es) * 1993-03-23 1995-11-16 Uriach & Cia Sa J Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas.
US5763431A (en) * 1993-08-20 1998-06-09 Jackson; Meyer B. Method for regulating neuropeptide hormone secretion
US5504090A (en) * 1994-03-30 1996-04-02 Trustees Of The University Of Pennsylvania Compositions and methods for the prevention and treatment of ischemia-reperfusion organ injury
DE4421433C1 (de) * 1994-06-18 1995-06-08 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Wirkstoffen, die Kohlenmonoxid-Quellen darstellen, Verfahren zu seiner Herstellung und seine Verwendung
US5476764A (en) * 1994-09-16 1995-12-19 The Regents Of The University Of California Method using CO for extending the useful shelf-life of refrigerated red blood cells
US6066333A (en) * 1994-09-22 2000-05-23 William Harvey Research Limited Pharmaceutical control of inflammation
US5664563A (en) * 1994-12-09 1997-09-09 Cardiopulmonary Corporation Pneumatic system
US5914316A (en) * 1994-12-16 1999-06-22 Washington University Method of inhibiting intimal hyperplasia
US5712293A (en) * 1995-06-07 1998-01-27 Sepracor, Inc. Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride
FR2735382B1 (fr) * 1995-06-15 1997-07-25 Air Liquide Installation de production de monoxyde de carbone incorporant une unite de separation cryogenique
ES2217313T3 (es) * 1995-06-30 2004-11-01 Zymogenetics, Inc. Bencenosulfonamidas o sulfonilureas de 4-(2-(n-(-2-carboxamidoindol)aminoetilo) como antagonistas del pdfg.
PT914103E (pt) * 1996-04-05 2006-09-29 Gen Hospital Corp Tratamento de uma hemoglobinopatia
US6069132A (en) * 1996-08-14 2000-05-30 Revanker; Ganapathi R. Phosphazole compounds
US8128963B2 (en) * 1996-09-27 2012-03-06 The Trustees Of Columbia University In The City Of New York Methods for treating ischemic disorders using carbon monoxide
WO1998013058A1 (en) * 1996-09-27 1998-04-02 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
US6316403B1 (en) * 1996-09-27 2001-11-13 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
US6203991B1 (en) * 1998-08-21 2001-03-20 The Regents Of The University Of Michigan Inhibition of smooth muscle cell migration by heme oxygenase I
US7678390B2 (en) * 1999-04-01 2010-03-16 Yale University Carbon monoxide as a biomarker and therapeutic agent
US20050250688A1 (en) * 1999-04-01 2005-11-10 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
FR2812197B1 (fr) * 2000-07-27 2003-01-03 Air Liquide Sante Int Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
FR2816212A1 (fr) * 2000-11-03 2002-05-10 Air Liquide Sante Int Utilisation de monoxyde de carbone (co) dans le traitement des inflammations du systeme cardiovasculaire
IL157580A0 (en) * 2001-03-20 2004-03-28 Glaxo Group Ltd Inhalation drug combination
WO2002078684A2 (en) * 2001-03-30 2002-10-10 Sangstat Medical Corporation Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
EP1395241B9 (en) * 2001-05-25 2005-06-15 Medtronic, Inc. Implantable medical device with controllable gaseous agent release system
NZ562962A (en) * 2001-06-21 2009-08-28 Fritz H Bach Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
EP1476168A2 (en) * 2002-02-04 2004-11-17 ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
US7364757B2 (en) * 2002-02-13 2008-04-29 University Of Pittsburgh Of The Commonwealth System Of Higher Education Methods of treating vascular disease
HRP20040972A2 (en) * 2002-04-15 2005-06-30 University Of Pittsburgh Of The Commonwealth Systeyale University Methods of treating ileus
AU2003226366A1 (en) * 2002-04-15 2003-11-03 Beth Israel Deaconess Medical Center Use of heme oxygenase-1 and products of heme degradation
RS91104A (sr) * 2002-04-15 2007-02-05 University Of Pittsburgh Of The Commonwealth System Of Higher Education, Postupci za lečenje nekrotizujućeg enterokolitisa
PL205066B1 (pl) * 2002-05-17 2010-03-31 Univ Pittsburgh Zastosowanie tlenku węgla do wytwarzania kompozycji farmaceutycznej
PL374375A1 (en) * 2002-06-05 2005-10-17 Yale University Methods of treating angiogenesis, tumor growth, and metastasis
EA200500062A1 (ru) * 2002-06-21 2005-06-30 Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн Фармацевтическое применение оксида азота, гемоксигеназы-1 и продуктов деградации гема

Also Published As

Publication number Publication date
CN1719975A (zh) 2006-01-11
RS20050344A (sr) 2007-11-15
WO2004043341A3 (en) 2004-07-15
NO20052348L (no) 2005-08-02
JP2006514621A (ja) 2006-05-11
PL377733A1 (pl) 2006-02-06
AU2003283982A1 (en) 2004-06-03
WO2004043341A2 (en) 2004-05-27
US20040228930A1 (en) 2004-11-18
EA200500782A1 (ru) 2005-10-27
CA2504604A1 (en) 2004-05-27
MXPA05004924A (es) 2005-08-18
HRP20050389A2 (en) 2005-08-31
EP1558084A4 (en) 2008-04-30
EP1558084A2 (en) 2005-08-03

Similar Documents

Publication Publication Date Title
NO20052348D0 (no) Behandling av hemoragisk sjokk
CY2015015I1 (el) Παραγωγη τιακουμυκινης
EP1583997A4 (en) Photoresist DISTANCE
DK1944322T3 (da) Behandling af TNFalfa-relaterede sygdomme
NO20052914D0 (no) Terapeutiske forbindelser
NO20052058D0 (no) Behandling av influensa.
FR2838446B1 (fr) Melanges de stabilisants
NO20033203D0 (no) Terapeutiske heterocykliske forbindelser
NO20052894D0 (no) 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
JP2006502186A5 (ja) β-グルカンの使用
SE0502484L (sv) Behandling av neurodegenerativa tillstånd
NO20044916L (no) Preparater av sulfinylacetamid
NO20041968L (no) Anvendelse av cystationin
DK1553950T3 (da) Terapeutisk behandling
DE60326190D1 (de) des Körpers
NO20050689L (no) Terapeutisk anvendelse
NO20052814D0 (no) Cytomodulerende peptider for behandling av interstitielle cystitt
IS6884A (is) Aðferðir við að nýta líffræðilegan fjölbreytileika
DE502004011589D1 (de) Silylierte carboxamide
DE602004030779D1 (de) Angehen des problems des schrittmachersyndroms
FR2837224B1 (fr) Bonde traitante
GB0217493D0 (en) Novel methods of treatment
NO20033160D0 (no) Anordning for behandling av gravann
NO20034972L (no) Behandling av ADHD
EP1511474A4 (en) PROCESSING PROCESS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application